Comparative histopathology of endomyocardial biopsies in chagasic and non-chagasic heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 20, Issue 5, 2001, Pages 534-543

  Marcelino De Souza, Márcia ^a,c   Franco, Marcello ^a   Rodrigues Almeida, Dirceu ^b   Viana Diniz, Roseane ^b   Arruda Mortara, Renato ^c   Da Silva, Solange ^c   Reis Da Silva Patrício, Francy ^a  

^a Departamento De Patologia   (Brazil)

^b Disciplina De Cardiologia   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; BIOPSY; CARDIOMEGALY; CHAGAS CARDIOMYOPATHY; ENDOCARDIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; ISCHEMIA; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; RECURRENCE; VASCULITIS;

EID: 0035002702     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00320-X     Document Type: Article

References (53)

1. Invited review. Chronic chagasic cardiopathy; the product of a turbulent host-parasite relationship
2. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8 and IL-2r by mitogen-activated helper and cytotoxic human lymphocytes
3. Autoimmunity in Chagas'disease cardiomyopathy; biological relevance of a cardiac myosin-specific epitope cross-reactive to an immunodominant Trypanosoma cruzi antigen
4. Cardiac transplantation; recipient selection, donor procurement, and medical follow-up. A statement for health professional from the committee on cardiac transplantation of the council of clinical cardiology, American Heart Association
5. Heart transplantation as a treatment for patients with end-stage Chagas' heart disease
6. Heart transplantation in Chagas' disease. 10 years after the initial experience
7. Heart transplantation for Chagas' cardiomyopathy
8. Long-term follow-up after heart transplantation in Chagas' disease
9. Improved results after heart transplantation for treatment of Chagas' heart disease with reduced doses of cyclosporine
10. Heart transplants for patients with Chagas' heart disease
11. Heart transplantation of chronic Chagas' heart disease
12. Studies on orthotopic homotransplantation of the canine heart
13. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection; heart rejection study group
14. Distribution of epitopes of Trypanosoma cruzi amastigotes during the intracellular life cycle within mammalian cells
15. Clinical course of Chagas' heart disease; a comparison with dilated cardiomyopathy
16. The Quilty lesion enigma; Focal apoptosis/necrosis and lymphocyte subsets in human cardiac allografts
17. Endomyocardial biopsy diagnosis of acute rejection in cardiac allografts
18. Endomyocardial lymphocytic infiltrates in cardiac transplant recipients. Incidence and characterization
19. Endomyocardial lymphocytic infiltrates after heart transplantation
20. The registry of the International Society for Heart and Lung Transplantation; Sixteenth Official Report
21. Rejection after cardiac transplantation. A time-related risk factor analysis
22. Results of heart transplantation for active lymphocytic myocarditis
23. Cardiac transplantation in patients with active myocarditis
24. A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction
25. 'Autoimmune rejection' of neonatal heart transplants in experimental Chagas' disease is a parasite-specific response to infected host tissue
26. Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease
27. Suppression of cellular responses in mice during Trypanosoma cruzi infection
28. Acquired cell-mediated immunodepression in acute Chagas'disease
29. Trypanosoma cruzi-induced suppression of IL-2 production. Evidence for the presence of IL-2 producing cells
30. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis; comparison with myocardial rejection process
31. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections
32. NaAn 'in situ'quantitative immunohistochemical study of cytokines and IL-2r+ in chronic human chagasic myocarditis; correlation with the presence of myocardial Trypanosoma cruzi antigens
33. Cellular immunity to Trypanosoma cruzi is mediated by T cells (CD4+)
34. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi
35. Different Trypanosoma cruzi strains promote neuromyopathic damage mediated by distinct T lymphocyte subsets
36. Human cardiac transplantation; evaluation of morphological changes in serial endomyocardial biopsies
37. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone
38. Pathologic changes in long-term transplanted heart; A morphometric study of myocardial hipertrophy, vascularity and fibrosis
39. Collagen profile in the transplanted heart
40. Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis
41. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation
42. Long-term hemodynamic results after cardiac transplantation
43. Early and late hemodynamic evaluation after cardiac transplantation; A study of 28 cases
44. Donor heart-related variables and early mortality after heart transplantation
45. Myocardial changes in cardiac transplant-associated coronary arteriosclerosis; potential for timely diagnosis
46. Predictive value of myocardial pathology in endomyocardial biopsies from heart transplant recipients with graft arteriosclerosis (abstract)
47. The pathology of heart allograft rejection
48. Heart transplantation-associated perioperative ischemia myocardial injury. Morphological features and clinical significance